FDA authorises CamDiab’s CamAPS FX artificial pancreas app
The US Food and Drug Administration (FDA) has granted authorisation for CamDiab’s adaptive hybrid closed-loop CamAPS FX app, marking a significant milestone in diabetes care technology. The artificial pancreas app, which functions as an ‘interoperable …